Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2005 1
2006 3
2007 1
2009 2
2010 5
2011 2
2012 1
2015 1
2016 1
2018 2
2020 1
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal MR-based proton-density fat fraction (PDFF) and T2* for the assessment of associations between bone marrow changes and myelotoxic chemotherapy.
Gassert FG, Kranz J, Gassert FT, Schwaiger BJ, Bogner C, Makowski MR, Glanz L, Stelter J, Baum T, Braren R, Karampinos DC, Gersing AS. Gassert FG, et al. Among authors: bogner c. Eur Radiol. 2024 Apr;34(4):2437-2444. doi: 10.1007/s00330-023-10189-y. Epub 2023 Sep 11. Eur Radiol. 2024. PMID: 37691079 Free PMC article.
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. Eichhorst B, et al. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. N Engl J Med. 2023. PMID: 37163621 Clinical Trial.
Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals.
Denker S, Bittner A, Frick M, Kase J, Hoffmann J, Trenker C, Keller U, Bogner C, Hüttmann A, Dürig J, Janz M, Mathas S, Marks R, Krohn U, Na IK, Bullinger L, Schmitt CA. Denker S, et al. Among authors: bogner c. Leuk Lymphoma. 2022 Jan;63(1):84-92. doi: 10.1080/10428194.2021.1964024. Epub 2021 Aug 20. Leuk Lymphoma. 2022. PMID: 34414850
The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.
Biberacher V, Decker T, Oelsner M, Wagner M, Bogner C, Schmidt B, Kreitman RJ, Peschel C, Pastan I, Meyer Zum Büschenfelde C, Ringshausen I. Biberacher V, et al. Among authors: bogner c. Haematologica. 2012 May;97(5):771-9. doi: 10.3324/haematol.2011.049155. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180432 Free PMC article.
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.
Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M; German CLL Study Group (GCLLSG). Eichhorst BF, et al. Blood. 2011 Feb 10;117(6):1817-21. doi: 10.1182/blood-2010-04-282228. Epub 2010 Dec 7. Blood. 2011. PMID: 21139079 Free article.
Apoptosis: embedded in membranes.
Bogner C, Leber B, Andrews DW. Bogner C, et al. Curr Opin Cell Biol. 2010 Dec;22(6):845-51. doi: 10.1016/j.ceb.2010.08.002. Epub 2010 Aug 26. Curr Opin Cell Biol. 2010. PMID: 20801011 Review.
22 results